Praluent (alirocumab) is a brand-name subcutaneous injection that’s prescribed for high cholesterol and lowering certain risks. Praluent isn’t known to interact with other drugs or supplements ...

Sanofi and Regeneron’s Praluent may still not be cost effective compared to other cholesterol-lowering drugs despite a recent price cut, a new study has claimed. The drug's high price point has ...

"The dosing of the first human with such an investigational ... and Sanofi/Regeneron's Praluent (alirocumab) – which reached the market several years ago . Slow growth has meant they haven ...

QUESTION: Watch out for serious drug interactions with Preparation H! A few years ago, I was taking a beta blocker drug ...

• Adjust starting time of warfarin based on CrCl as follows: º CrCl ≥50mL/min: Start warfarin 3 days before discontinuing dabigatran º CrCl 30−50mL/min: Start warfarin 2 days before ...

At AHA 2024, clinical trial results were presented from the ongoing open-label extension trial, LIBERATE-OLE, involving ...

The drug comes as a solution for injection under the skin. How often you’ll receive a dose depends on the condition being treated. Dupixent is used to treat certain cases of: Dupixent comes as a ...

Reactions can come back quickly and may require a second dose as well as emergency medical treatment ... They include ...

Lerodalcibep, like established PCSK9 inhibitors such as Praluent and Repatha, target the PCSK9 protein to help reduce LDL ...

While Regeneron's Praluent has entered the multi-billion-dollar ... commercial potential of its Eylea franchise (including low-dose Eylea and high-dose Eylea HD) and the productivity of its ...

The research challenges long-held assumptions about IL-12 s behavior in the body and offers a path toward safer and more effective dosing regimens. A team of Rice University bioengineers has ...